Status:
COMPLETED
Stability of Uncemented Medially Stabilized TKA
Lead Sponsor:
Oslo University Hospital
Collaborating Sponsors:
Medacta International SA
Conditions:
Knee Osteoarthritis
Eligibility:
All Genders
50-75 years
Phase:
NA
Brief Summary
Total joint replacement is an efficacious treatment for osteoarthritis of hips and knees. Both total knee replacement (TKR) and total hip replacements (THR) have excellent implant survivorship. Howeve...
Detailed Description
Worldwide the number of patients requiring treatment for osteoarthritis is increasing (Kurtz et al. 2007). Especially the young population will increase within the group of patients for arthroplasty (...
Eligibility Criteria
Inclusion
- Patients referred to Oslo University Hospital, Ullevål for knee replacement surgery will be included to this study for a total of 30 subjects.
Exclusion
- 75 and more years of age at the time of surgery
- Use of walking aids because of other muscoloskeletal and neuromuscular problems
- Preoperative diagnosis other than osteoarthritis and avascular necrosis (e.g. rheumatoid arthritis, tumors)
- Obesity with BMI\>35
- Lateral collateral ligament deficient knee
- Reduced bone quality in the proximal tibia before surgery
- Insufficient language to answer questionnaires in Norwegian
Key Trial Info
Start Date :
September 4 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 10 2024
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT04017533
Start Date
September 4 2021
End Date
October 10 2024
Last Update
November 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oslo University Hospital
Oslo, Norway, 0470